PowerUp Acquisition Corp. Approves Merger with Aspire Biopharma

Published 10/02/2025, 23:02
PowerUp Acquisition Corp. Approves Merger with Aspire Biopharma

PowerUp Acquisition Corp. (NASDAQ:PWUP), a special purpose acquisition company currently valued at $88.29 million, has announced the successful approval of its merger with Aspire Biopharma, Inc., a pharmaceutical company, at an extraordinary general meeting of shareholders held on Monday. According to InvestingPro data, PWUP shares have shown remarkable momentum with a 21% gain over the past week. The merger, which is expected to close by February 17, 2025, received overwhelming support with approximately 92.8% of the issued and outstanding Class A ordinary shares present or represented by proxy at the meeting.

The approval paves the way for the combined entity to be named Aspire Biopharma Holdings, Inc., with the expectation of trading on the Nasdaq Stock Market LLC under the new ticker symbols "ASBP" for common stock and "ASBPW" for public warrants. The stock currently trades at $12.61, and InvestingPro analysis indicates the shares are slightly overvalued at current levels. Subscribers can access 5 additional ProTips and comprehensive financial metrics to better evaluate this merger opportunity. In connection with the merger, shareholders voted on several related proposals, including the increase of authorized share capital, director removal policies, bylaw amendments, and the election of directors to serve staggered terms.

Additionally, shareholders approved a domestication proposal to transfer PowerUp by way of continuation to Delaware and to change the company’s name post-merger. Furthermore, the adoption of the Aspire Biopharma Holdings, Inc. 2024 Omnibus Incentive Plan was approved, aimed at providing incentives for employees and directors.

In the lead-up to the meeting, 507,631 Class A ordinary shares were validly elected for redemption, resulting in approximately $5,802,222.33 being removed from the company’s trust account to pay those shareholders, equating to $11.43 per share.

The merger is subject to the satisfaction or waiver of certain closing conditions as described in the proxy statement/prospectus filed with the SEC. This transformative event for PowerUp Acquisition Corp. is based on a press release statement and is expected to significantly impact the company’s future operations and market positioning. InvestingPro data reveals the company currently maintains a weak financial health score, with short-term obligations exceeding liquid assets, highlighting the importance of this strategic merger for its future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.